174 related articles for article (PubMed ID: 27798967)
1. Low Rates of Transmitted Drug Resistance Among Newly Identified HIV-1 Seroconverters in Rural Rakai, Uganda.
Reynolds SJ; Ssempijja V; Galiwango R; Ndyanabo A; Nakigozi G; Lyagoba F; Nazziwa J; Redd A; Lamers SL; Gray R; Wawer M; Serwadda D; Quinn TC
AIDS Res Hum Retroviruses; 2017 May; 33(5):448-451. PubMed ID: 27798967
[TBL] [Abstract][Full Text] [Related]
2. Surveillance of HIV-1 pol transmitted drug resistance in acutely and recently infected antiretroviral drug-naïve persons in rural western Kenya.
Onywera H; Maman D; Inzaule S; Auma E; Were K; Fredrick H; Owiti P; Opollo V; Etard JF; Mukui I; Kim AA; Zeh C
PLoS One; 2017; 12(2):e0171124. PubMed ID: 28178281
[TBL] [Abstract][Full Text] [Related]
3. Short communication: HIV type 1 transmitted drug resistance and evidence of transmission clusters among recently infected antiretroviral-naive individuals from Ugandan fishing communities of Lake Victoria.
Nazziwa J; Njai HF; Ndembi N; Birungi J; Lyagoba F; Gershim A; Nakiyingi-Miiro J; Nielsen L; Mpendo J; Nanvubya A; Debont J; Grosskurth H; Kamali A; Seeley J; Kaleebu P;
AIDS Res Hum Retroviruses; 2013 May; 29(5):788-95. PubMed ID: 23173702
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of transmitted antiretroviral resistance and distribution of HIV-1 subtypes among patients with recent infection in Catalonia (Spain) between 2003 and 2005.
Romero A; Sued O; Puig T; Esteve A; Pumarola T; Casabona J; González V; Matas L; Tural C; Rodrigo I; Margall N; Domingo P; Casanova A; Ferrer E; Caballero E; Ribera E; Farré J; Puig T; Amengual MJ; Navarro G; Prat JM; Masabeu A; Simó JM; Villaverde CA; Barrufet P; Sauca MG; Ortin X; Ortí A; Navarro R; Euras JM; Vilaró J; Villà MC; Montull S; Vilanova C; Pujol F; Díaz O; Miró JM;
Enferm Infecc Microbiol Clin; 2011; 29(7):482-9. PubMed ID: 21543135
[TBL] [Abstract][Full Text] [Related]
5. Transmitted HIV Type 1 drug resistance and Non-B subtypes prevalence among seroconverters and newly diagnosed patients from 1992 to 2005 in Italy.
Riva C; Lai A; Caramma I; Corvasce S; Violin M; Dehò L; Prati F; Rossi C; Colombo MC; Capetti A; Franzetti M; Rossini V; Tambussi G; Ciccozzi M; Suligoi B; Mussini C; Rezza G; Balotta C
AIDS Res Hum Retroviruses; 2010 Jan; 26(1):41-9. PubMed ID: 20055587
[TBL] [Abstract][Full Text] [Related]
6. HIV transmitted drug resistance in adult and pediatric populations in Panama.
Castillo J; Arteaga G; Mendoza Y; Martínez AA; Samaniego R; Estripeaut D; Page KR; Smith RE; Sosa N; Pascale JM
Rev Panam Salud Publica; 2011 Dec; 30(6):649-56. PubMed ID: 22358417
[TBL] [Abstract][Full Text] [Related]
7. Epidemiological Surveillance of HIV-1 Transmitted Drug Resistance in Spain in 2004-2012: Relevance of Transmission Clusters in the Propagation of Resistance Mutations.
Vega Y; Delgado E; Fernández-García A; Cuevas MT; Thomson MM; Montero V; Sánchez M; Sánchez AM; Pérez-Álvarez L;
PLoS One; 2015; 10(5):e0125699. PubMed ID: 26010948
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Transmitted Drug-Resistance Mutations and Polymorphisms in HIV-1 Reverse Transcriptase, Protease, and gp41 Sequences Among Recent Seroconverters in Southern Poland.
Smoleń-Dzirba J; Rosińska M; Kruszyński P; Bratosiewicz-Wąsik J; Wojtyczka R; Janiec J; Szetela B; Beniowski M; Bociąga-Jasik M; Jabłonowska E; Wąsik TJ; The Cascade Collaboration In EuroCoord A
Med Sci Monit; 2017 Feb; 23():682-694. PubMed ID: 28167814
[TBL] [Abstract][Full Text] [Related]
9. Transmitted HIV type 1 drug resistance in newly diagnosed Cuban patients.
Machado LY; Dubed M; Díaz H; Ruiz N; Romay D; Váldes N; Blanco M; Silva E
AIDS Res Hum Retroviruses; 2013 Feb; 29(2):411-4. PubMed ID: 22985307
[TBL] [Abstract][Full Text] [Related]
10. Low drug resistance levels among drug-naive individuals with recent HIV type 1 infection in a rural clinical cohort in southwestern Uganda.
Ssemwanga D; Kapaata A; Lyagoba F; Magambo B; Nanyonjo M; Mayanja BN; Parry CM; Kaleebu P
AIDS Res Hum Retroviruses; 2012 Dec; 28(12):1784-7. PubMed ID: 22616647
[TBL] [Abstract][Full Text] [Related]
11. Moderate prevalence of transmitted drug resistance and high HIV-1 genetic diversity in patients from Mato Grosso State, Central Western Brazil.
Ferreira AS; Cardoso LP; Stefani MM
J Med Virol; 2011 Aug; 83(8):1301-7. PubMed ID: 21678433
[TBL] [Abstract][Full Text] [Related]
12. The Emergence of HIV-1 Transmitted Drug Resistance Mutations Among Antiretroviral Therapy-naive Individuals in Buleleng, Bali, Indonesia.
Megasari NLA; Oktafiani D; Fitriana E; Khairunisa SQ; Kotaki T; Ueda S; Nasronudin N; Soetjipto S; Kameoka M
Acta Med Indones; 2019 Jul; 51(3):197-204. PubMed ID: 31699942
[TBL] [Abstract][Full Text] [Related]
13. Transmitted drug-resistance in human immunodeficiency virus-infected adult population in El Salvador, Central America.
Holguín Á; Yebra G; Martín L; de Pineda AT; Ruiz LE; Quezada AY; Nieto AI; Escobar G
Clin Microbiol Infect; 2013 Dec; 19(12):E523-32. PubMed ID: 23782115
[TBL] [Abstract][Full Text] [Related]
14. Surveillance of Transmitted Drug Resistance in HIV-1-Infected Youths Aged 16 to 25 Years, a Decade After Scale-up of Antiretroviral Therapy in Hebei, China.
Lu X; Kang X; Liu Y; Li Y; Chen S; Li J; Cui Z
AIDS Res Hum Retroviruses; 2017 Apr; 33(4):359-363. PubMed ID: 27750023
[TBL] [Abstract][Full Text] [Related]
15. Cross-clade simultaneous HIV drug resistance genotyping for reverse transcriptase, protease, and integrase inhibitor mutations by Illumina MiSeq.
Dudley DM; Bailey AL; Mehta SH; Hughes AL; Kirk GD; Westergaard RP; O'Connor DH
Retrovirology; 2014 Dec; 11():122. PubMed ID: 25533166
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of transmitted HIV-1 drug resistance among young adults attending HIV counselling and testing clinics in Kigali, Rwanda.
Mutagoma M; Ndahimana Jd; Kayirangwa E; Dahourou AG; Balisanga H; DeVos JR; McAlister D; Yang C; Bertagnolio S; Riedel DJ; Nsanzimana S
Antivir Ther; 2016; 21(3):247-51. PubMed ID: 26458150
[TBL] [Abstract][Full Text] [Related]
17. Global HIV-1 transmitted drug resistance in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.
Baxter JD; Dunn D; White E; Sharma S; Geretti AM; Kozal MJ; Johnson MA; Jacoby S; Llibre JM; Lundgren J;
HIV Med; 2015 Apr; 16 Suppl 1(0 1):77-87. PubMed ID: 25711326
[TBL] [Abstract][Full Text] [Related]
18. Short communication: emerging transmitted HIV type 1 drug resistance mutations among patients prior to start of first-line antiretroviral therapy in middle and low prevalence sites in China.
Wang X; He C; Xing H; Liao L; Xu X; He J; Liu Y; Ling H; Liang S; Hsi JH; Ruan Y; Shao Y
AIDS Res Hum Retroviruses; 2012 Dec; 28(12):1637-9. PubMed ID: 22822770
[TBL] [Abstract][Full Text] [Related]
19. Increasing HIV-1 Drug Resistance Between 2010 and 2012 in Adults Participating in Population-Based HIV Surveillance in Rural KwaZulu-Natal, South Africa.
Manasa J; Danaviah S; Lessells R; Elshareef M; Tanser F; Wilkinson E; Pillay S; Mthiyane H; Mwambi H; Pillay D; de Oliveira T
AIDS Res Hum Retroviruses; 2016 Aug; 32(8):763-9. PubMed ID: 27002368
[TBL] [Abstract][Full Text] [Related]
20. Transmitted Drug Resistance Mutations in Antiretroviral-Naïve Injection Drug Users with Chronic HIV-1 Infection in Iran.
Memarnejadian A; Menbari S; Mansouri SA; Sadeghi L; Vahabpour R; Aghasadeghi MR; Mostafavi E; Abdi M
PLoS One; 2015; 10(5):e0126955. PubMed ID: 25962088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
